Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AbbVie announced its full-year financial guidance for 2026

AbbVie announced its full-year financial guidance for 2026

老虎证券老虎证券2026/04/03 20:17
Show original
According to the guidelines, after taking into account the impact of the acquisition of IPR&D (In-Process Research and Development projects with already obtained intellectual property) and milestone expenses occurring in the first quarter of 2026, the company expects full-year adjusted diluted earnings per share to be between $13.96 and $14.16.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

EUR/USD: ECB hawks lag Fed – ING

FXStreet•2026/11/13 09:48
EUR/USD: ECB hawks lag Fed – ING

Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027

Goldman Sachs maintains its "Buy" rating on Applied Materials but lowers its 12-month target price from $670 to $580.

智通财经•2026/11/13 09:18
Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027